Summit Therapeutics Inc. announced that data from the Phase III HARMONi-6 trial will be highlighted during the prestigious Presidential Symposium at the upcoming European Society for Medical Oncology (ESMO) Congress 2025, taking place in Berlin, Germany, from October 17–21, 2025.…
Exact Sciences Corp., a leader in cancer screening and diagnostic testing, has announced a new awareness campaign in collaboration with actor and horror film icon Matthew Lillard. The initiative aims to motivate adults aged 45 and older to get screened…
Genentech’s Giredestrant Boosts PFS in ER+ Advanced Breast Cancer Genentech, a member of the Roche Group, announced encouraging results from the Phase III evERA study evaluating its investigational oral selective estrogen receptor degrader (SERD), giredestrant, in combination with everolimus. The…
Geneos Therapeutics, a clinical-stage biotherapeutics company pioneering personalized immunotherapies for cancer (PICs), has announced remarkable clinical results from two long-term patients treated with its novel DNA-based therapy. One patient with glioblastoma multiforme (GBM), an aggressive brain cancer, and another with…
Almirall, S.A., a global biopharmaceutical company dedicated to medical dermatology, announced new long-term results from the POSITIVE study, presented as a late-breaker at the 34th Congress of the European Academy of Dermatology and Venereology (EADV 2025) in Paris. The POSITIVE…
Arlington Capital Partners a Washington, D.C.–based private investment firm with a focus on government-regulated industries, announced today that its portfolio company TEAM Technologies (“TEAM Tech”) has acquired TAG3 Engineering, LLC (“TAG3”). TEAM Tech is a leading provider of end-to-end outsourced…
Areteia Reports Positive Phase III Results for Oral Dexpramipexole in Eosinophilic Asthma Areteia Therapeutics, Inc. announced today that its Phase III EXHALE-4 clinical trial has met key efficacy and safety endpoints for dexpramipexole, an investigational oral therapy being developed as…
Orano Med, the oncology-focused subsidiary of the Orano group, has announced a significant milestone in the construction of its Advanced Thorium Extraction Facility (ATEF) in Bessines-sur-Gartempe, near Limoges, France. The project has reached the watertight or “dry-in” phase, meaning sealing…
Seaport Therapeutics a clinical-stage biopharmaceutical company developing next-generation neuropsychiatric medicines, announced that the first participant has been dosed in its Phase 1 clinical study of GlyphAgo™ (SPT-320 or Glyph Agomelatine). GlyphAgo is a novel “Glyphed” oral prodrug of agomelatine designed…
European Students Excel in Global Cambridge Science Competition Three student teams from across Europe have been honored with awards in the prestigious 2025 Cambridge Science Competition, an international initiative hosted by the International Education division at Cambridge University Press &…
LG Display Receives UL Solutions Eyesafe Verification for OLED TVs and Monitors Introduction of the Verification Achievement UL Solutions has announced that LG Display’s organic light-emitting diode (OLED) televisions and monitors are the first to achieve UL Solutions Eyesafe Verification.…
iECURE Presents Promising Data for ECUR-506 in OTC-HOPE Phase 1/2 Trial at 2025 ACMG Annual Meeting iECURE, Inc., a gene editing company focused on developing mutation-agnostic in vivo gene insertion therapies for liver disorders, has shared encouraging results from the…